CD36 and hepatocellular carcinoma: On the other hand, CD36 knockdown in HCC cells (SMMC-7721 and HepG2) upregulates FA β-oxidation, activates the lipophagy pathway, reduces hepatic lipid accumulation (Li et al., 2019), impairs cell proliferation, and decreased migration and invasion (Luo et al., 2021).